• agilon health inc AGL.N reported a quarterly adjusted loss of 26 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -41 cents. The mean expectation of twenty one analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -27 cents to -18 cents per share.

• Revenue rose 44.2% to $1.52 billion from a year ago; analysts expected $1.52 billion.

• agilon health inc's reported EPS for the quarter was a loss of 26 cents​.

• The company reported a quarterly loss of $105.79 million.

• agilon health inc shares had risen by 91.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 18 "hold" and 2 "sell" or "strong sell."

• The average consensus recommendation for the healthcare facilities & services peer group is also "hold"

Wall Street's median 12-month price target for agilon health inc is $2.50

This summary was machine generated from LSEG data February 25 at 10:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)